S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:SWAV

Shockwave Medical - SWAV Stock Forecast, Price & News

$217.92
+3.68 (+1.72%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$214.57
$220.00
50-Day Range
$175.41
$215.02
52-Week Range
$113.36
$320.54
Volume
307,623 shs
Average Volume
489,031 shs
Market Capitalization
$7.95 billion
P/E Ratio
38.23
Dividend Yield
N/A
Price Target
$247.40

Shockwave Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
13.5% Upside
$247.40 Price Target
Short Interest
Healthy
4.14% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
0.36mentions of Shockwave Medical in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$13.21 M Sold Last Quarter
Proj. Earnings Growth
15.82%
From $3.92 to $4.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.81 out of 5 stars

Medical Sector

57th out of 995 stocks

Surgical & Medical Instruments Industry

5th out of 103 stocks


SWAV stock logo

About Shockwave Medical (NASDAQ:SWAV) Stock

Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Stock News Headlines

Modern Day Options Trading For Beginners!
These days it takes more than willpower to succeed on Wall Street and for new traders, even small mistakes can sink an account! With "Your Guide To Successful Options Trading" by expert Wendy Kirkland, you can avoid new trader pitfalls and learn to earn in this vicious market. pixel
3 Supercharged Stocks That Still Look Unstoppable
Top Healthcare Stocks for March 2023
Modern Day Options Trading For Beginners!
These days it takes more than willpower to succeed on Wall Street and for new traders, even small mistakes can sink an account! With "Your Guide To Successful Options Trading" by expert Wendy Kirkland, you can avoid new trader pitfalls and learn to earn in this vicious market. pixel
Here’s Why ShockWave Medical (SWAV) Declined in Q4
SWAV ShockWave Medical, Inc.
See More Headlines
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Company Calendar

Last Earnings
2/16/2023
Today
3/27/2023
Next Earnings (Estimated)
5/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
1,001
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$247.40
High Stock Price Forecast
$310.00
Low Stock Price Forecast
$165.00
Forecasted Upside/Downside
+15.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

Net Income
$216 million
Pretax Margin
24.67%

Debt

Sales & Book Value

Annual Sales
$489.73 million
Cash Flow
$6.12 per share
Book Value
$14.15 per share

Miscellaneous

Free Float
35,072,000
Market Cap
$7.82 billion
Optionable
Not Optionable
Beta
0.97

Key Executives

  • Douglas Evan GodshallDouglas Evan Godshall
    President, Chief Executive Officer & Director
  • Mike Maszy
    Senior Vice President-Operations
  • Daniel Puckett
    Chief Financial Officer & Secretary
  • Beaux Alexander
    Vice President-Clinical Affairs
  • W. Patrick Stephens
    Vice President-Research & Development













SWAV Stock - Frequently Asked Questions

Should I buy or sell Shockwave Medical stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SWAV shares.
View SWAV analyst ratings
or view top-rated stocks.

What is Shockwave Medical's stock price forecast for 2023?

9 Wall Street research analysts have issued 1 year price targets for Shockwave Medical's shares. Their SWAV share price forecasts range from $165.00 to $310.00. On average, they anticipate the company's share price to reach $247.40 in the next year. This suggests a possible upside of 14.8% from the stock's current price.
View analysts price targets for SWAV
or view top-rated stocks among Wall Street analysts.

How have SWAV shares performed in 2023?

Shockwave Medical's stock was trading at $205.61 at the start of the year. Since then, SWAV stock has increased by 4.8% and is now trading at $215.56.
View the best growth stocks for 2023 here
.

When is Shockwave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our SWAV earnings forecast
.

How were Shockwave Medical's earnings last quarter?

Shockwave Medical, Inc. (NASDAQ:SWAV) released its quarterly earnings results on Thursday, February, 16th. The company reported $3.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $2.72. The company earned $144 million during the quarter, compared to the consensus estimate of $143.04 million. Shockwave Medical had a net margin of 44.10% and a trailing twelve-month return on equity of 59.99%. The company's revenue for the quarter was up 71.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.34 earnings per share.

What guidance has Shockwave Medical issued on next quarter's earnings?

Shockwave Medical issued an update on its FY 2023 earnings guidance on Wednesday, March, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $660.00 million-$680.00 million, compared to the consensus revenue estimate of $658.58 million.

What is Doug Godshall's approval rating as Shockwave Medical's CEO?

8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is Shockwave Medical's stock symbol?

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (2.80%), JPMorgan Chase & Co. (2.23%), Macquarie Group Ltd. (2.09%), Gilder Gagnon Howe & Co. LLC (1.95%), Geode Capital Management LLC (1.86%) and Artisan Partners Limited Partnership (1.85%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sofinnova Capital Vii Fcpr and Trinh Phung.
View institutional ownership trends
.

How do I buy shares of Shockwave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Shockwave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $215.56.

How much money does Shockwave Medical make?

Shockwave Medical (NASDAQ:SWAV) has a market capitalization of $7.87 billion and generates $489.73 million in revenue each year. The company earns $216 million in net income (profit) each year or $5.70 on an earnings per share basis.

How many employees does Shockwave Medical have?

The company employs 1,001 workers across the globe.

How can I contact Shockwave Medical?

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (877) 775-4846 or via email at investors@shockwavemedical.com.

This page (NASDAQ:SWAV) was last updated on 3/27/2023 by MarketBeat.com Staff